the rxponder trial and its impact on best clinical practice
Published 2 years ago • 420 plays • Length 17:07Download video MP4
Download video MP3
Similar videos
-
17:03
the rxponder trial and its impact on best clinical practice ecancer google chrome 2021 12 23 20
-
2:34
race and clinical outcomes in the rxponder trial
-
1:49
kalinsky discusses results from rxponder breast cancer clinical trial
-
33:42
important lessons from tailorx, mindact and rx-ponder:
-
0:38
rxponder: 21-gene assay informs chemotherapy benefit in hr node-positive breast cancer
-
2:02
oncotype dx for breast cancer
-
49:10
predictors of recurrence after a dcis diagnosis
-
2:21
phage display
-
9:35
mindact long-term results: 70-gene signature mammaprint to guide adjuvant chemotherapy use in br...
-
5:07
julie gralow, md, summarizes the rxponder trial from the 2020 san antonio breast cancer symposium
-
0:52
rxponder 2024 - amh to determine the benefit of chemotherapy in early breast cancer.
-
16:11
dr. julie r. gralow discusses findings from the rxponder study released at sabcs 2020
-
4:13
genomic predictors for treatment selection in er breast cancer: tailorx, mindact, and rxponder
-
2:50
rxponder: sparing chemotherapy in node-positive early-stage breast cancer
-
6:29
european guidelines for breast cancer treatment
-
47:21
asco 2023: highlights and analysis
-
7:16
clinical trials and breast cancer | benefits to the patient
-
2:22
kevin kalinsky, md, shares impressions of the rxponder clinical trial presented at sabcs 2020
-
1:47
can we decrease chemotherapy in ln premenopausal women based on genomic tests?
-
3:42
rxponder: is it all ofs?
-
33:23
oncotype dx breast recurrence score assay after tailorx and rxponder: what’s next?
-
0:38
the role of the oncotype dx assay in the management of patients with breast cancer